1 day-0.78%
1 week+5.21%
Current month+10.59%
1 month+69.47%
3 months+83.47%
1 week 378.5
Extreme 378.5
500
1 month 241.5
Extreme 241.5
500
Current year 163
Extreme 163
500
1 year 163
Extreme 163
500
3 years 163
Extreme 163
500
5 years 163
Extreme 163
500
10 years 163
Extreme 163
500
Change 5-day change 1-year change 3-year change Capi.($)
-0.78%+5.21% - - 186.52Cr
+4.16%+4.16%+49.37%+94.17% 7.47TCr
+0.46%-1.16%+23.36%+79.34% 5.88TCr
+0.17%-1.16%+3.59%+34.55% 4.84TCr
+0.50%-1.77%+331.24%+702.20% 4.28TCr
-0.72%-4.04%+25.90%+29.94% 4.28TCr
+0.34%-0.34%+5.66%+109.35% 4.12TCr
-0.11%+1.96%+9.19%+52.66% 3.11TCr
-2.07%+1.16%+35.00%+26.28% 3.03TCr
-0.50%-3.37%-9.42%-14.35% 2.4TCr
Average -0.07%+0.83%+52.65%+123.79% 3.96TCr
Weighted average by Cap. +0.48%-0.49%+55.51%+130.20%
Logo TLC BioSciences Corp.
TLC BioSciences Corp is a company specializing in proprietary lipid nanoparticles (LNPs) and lipid carrier drug delivery technologies. It is a biotechnology company dedicated to developing a diverse range of innovative nanomedicine products. The Company and its group primarily focus on developing innovative drugs covering orthopedics, pain management, antifungal infections, metabolic diseases, and immunotherapy by utilizing three proprietary technology platforms, includingBioSeizer controlled-release formulation technology, NanoX precision drug delivery technology, and Genosphere precision gene therapy delivery technology (collectively known as the LipAD technology platform). The Company's key assets include TLC590, TLC599, and TLC166.
Employees
-
Date Price Change Volume
07/26/07 NT$437.00 -1.58% 4,27,159
06/26/06 NT$444.00 -0.78% 7,74,766
05/26/05 NT$447.50 -5.39% 9,77,427
02/26/02 NT$473.00 +13.43% 9,35,708
01/26/01 NT$417.00 +3.86% 6,20,064
  1. Stock Market
  2. Stocks
  3. 7924 Stock